Lord, Abbett & Co. LLC Ngm Biopharmaceuticals Inc Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$10.58 - $17.5 $8,464 - $14,000	-800 Reduced 0.6%	132,426 $1.7 Million
Q1 2022 May 13, 2022	SELL	$13.81 - $18.6 $723,298 - $974,175	-52,375 Reduced 28.22%	133,226 $2.03 Million
Q4 2021 Feb 11, 2022	BUY	$17.26 - $22.02 $3,452 - $4,404	200 Added 0.11%	185,601 $3.29 Million
Q3 2021 Nov 09, 2021	SELL	$20.15 - $26.19 $74,555 - $96,903	-3,700 Reduced 1.96%	185,401 $3.9 Million
Q2 2021 Aug 11, 2021	BUY	$15.06 - $30.03 $2.85 Million - $5.68 Million	189,101 New	189,101 $3.73 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.